Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • atgc
    Junior Member
    • Aug 2010
    • 6

    Mapping and base calling

    Hello,

    I recently received sequencing data from Illumina's HiSeq. The reads are 100 bp, paired end. The data has been provided to us in fastq format.

    I have worked with PE sequencing earlier. However, initially, data was provided in a txt format which we imported into CLC Genomics Workbench. Does anyone know if the fastq format can be imported into CLC Genomics Workbench?
    Thanks for your help in advance.

    ATGC
  • sklages
    Senior Member
    • May 2008
    • 628

    #2
    Just works like importing the qseq files (what you probably did import before as txt). Select to import fastq.

    Comment

    • atgc
      Junior Member
      • Aug 2010
      • 6

      #3
      Thank you.

      Comment

      • boetsie
        Senior Member
        • Feb 2010
        • 245

        #4
        First of all; probably the 'older' .txt format was also a .fastQ format. CASAVA spits out a .txt file, which is basically a .fastQ file.

        Anyway; Best way to import Illumina Paired-end data is to go to 'File -> Import High-throughput sequencing data -> Illumina". Select here both paired-reads and choose your file format (.fastQ). See this link from CLC:
        Welcome to QIAGEN Digital Insights LabCorp uses QCI and HGMD to improve identification and interpretation of genetic variants within inhereited diseases.Read...


        Illumina HiSeq data can be treated the same as Illumina Genome Analyzer data.

        Comment

        • atgc
          Junior Member
          • Aug 2010
          • 6

          #5
          Initially the paired end read data that was given to me was two files/ sample - a forward and a reverse read. However this new data set includes 4 or more files / sample. I don't understand why this is.

          Comment

          • sklages
            Senior Member
            • May 2008
            • 628

            #6
            Originally posted by atgc View Post
            Initially the paired end read data that was given to me was two files/ sample - a forward and a reverse read. However this new data set includes 4 or more files / sample. I don't understand why this is.
            If this data has been generated via CASAVA 1.8 then this is due to the fact that every fastq file generated has a constant number of sequences (except for the last one which holds the remainder), but at most 16mio. So one lane of HiSeq data is almost always splitted into more than one read (fastq) file.

            E.g.
            Code:
            sample2_CGATGT_L003_R1_001.fastq.gz
            sample2_CGATGT_L003_R2_001.fastq.gz
            sample2_CGATGT_L003_R1_002.fastq.gz
            sample2_CGATGT_L003_R2_002.fastq.gz
            sample2_CGATGT_L003_R1_003.fastq.gz
            sample2_CGATGT_L003_R2_003.fastq.gz
            hth, Sven

            Comment

            • atgc
              Junior Member
              • Aug 2010
              • 6

              #7
              That helps. Thanks.

              Comment

              • atgc
                Junior Member
                • Aug 2010
                • 6

                #8
                I am getting an error when I import fastq reads into the CLC Genomics Workbench.

                The message reads as follows:

                "The data seems to be corrupt or originates from different sources since the input files contain different number of reads. The previous sequences have been properly saved but it is highly likely the import data is incomplete or defective. Please double-check the sources."

                I have two forward and two reverse fastq files. I tried to import only one of each and I still get the error when importing.

                Would anyone here know the source of this error or what it means.

                Thanks for your help in advance.
                Last edited by atgc; 06-27-2011, 02:01 PM.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                29 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-23-2026, 11:41 AM
                0 responses
                21 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                211 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                78 views
                0 reactions
                Last Post SEQadmin2  
                Working...